Endo International Enters Agreement To Buy Par Pharma For $8 Billion
May 18, 2015 at 11:57 AM EDT
The pharmaceutical industry saw another M&A bump this morning when Endo International said it entered into an agreement to purchase Par Pharmaceuticals for $8.05 billion.
